Pay in 4 interest-free payments of $20.00 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
RO 5185426 RO5185426 Vemurafenib
13)/t9-/m1/s1
Deregulation of CDK activity is a feature of almost all cancers and has led to the development of CDK inhibitors as anticancer agents
It acts as a competitive inhibitor of HMG CoA reductase Pravastatin competitively inhibits hepatic hydroxymethyl-glutaryl coenzyme A reductase
Pre-treatment with 1 μM inhibits migration to a greater extent in the non-gradient assay than in the gradient assay
AT-101 acetic acid - CAS# 866541-93-7 Size:Solid 2 mg RO 5185426 RO5185426 VemurafenibGossypol is an orally active polyphenolic aldehyde with potential antineoplastic activity. Derived primarily from unrefined cottonseed oil, gossypol induces cell cycle arrest at the G0 G1 phase, thereby inhibiting DNA replication and inducing apoptosis. This agent also inhibits cell signaling enzymes, resulting in inhibition of cell growth, and may act as a male contraceptive. Product information CAS Number: 866541 93 7 Molecular Weight: 578. 61